Premium
Allergic Fcε RI ‐ and pseudo‐allergic MRGPRX 2‐triggered mast cell activation routes are independent and inversely regulated by SCF
Author(s) -
Babina M.,
Guhl S.,
Artuc M.,
Zuberbier T.
Publication year - 2018
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.13301
Subject(s) - degranulation , population , immunology , mast cell , chemistry , allergic response , microbiology and biotechnology , receptor , biology , immunoglobulin e , medicine , biochemistry , antibody , environmental health
While allergic mast cell ( MC ) degranulation occurs by Fcε RI aggregation and varies in strength among subjects, the analogous pseudo‐allergic route was recently uncovered to proceed via MRGPRX 2. Here, we examine interindividual variability in skin MC responses to Fcε RI triggering vs those evoked by MRGPRX 2. While population‐based variability is comparable between the routes, Fcε RI ‐ and MRGPRX 2‐stimulated pathways are completely independent from each other, and responsiveness to one has therefore no predictive value for the other. Conversely, degranulation triggered by compound 48/80 is highly correlated to the process elicited by substance P. MRGPRX 2 mRNA shows pronounced population‐based variability (coefficient of variation 102.9%). Surprisingly, stem cell factor ( SCF ) as the MC ‐supportive mediator par excellence potently inhibits pseudo‐allergic degranulation, while it simultaneously promotes allergic stimulation via Fcε RI . We conclude that SCF can have selective MC ‐dampening functions. Clinically, the data imply that subjects highly reactive in one pathway are not automatically hyper‐responsive in terms of the alternative route.